Archana Vijayakumar
Company: OsoBio
Job title: Senior Director
Seminars:
Panel Discussion & Extended Q&A: Summarising the Progress & Promise of Upcoming MoAs, Understanding Disease Modifying Potential 3:45 pm
day: Conference Day Two
Showcasing Novel Liver-Targeted Mitochondrial Protonophores Approach for the Treatment of Obesity and Diabetes 1:15 pm
Leveraging mitochondrial uncoupling with synthetic protonophores as a clinically validated mechanism for weight loss Overcoming hyperthermia due to uncontrolled systemic uncoupling which has limited clinical development of synthetic protonophores Outlining pioneering efforts from OrsoBio which have created a portfolio of synthetic protonophores that demonstrate enhanced therapeutic margins owing to their livertargeted pharmacologyRead more
day: Conference Day Two